Abstract:Postpartum venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a critical complication occurring in the postpartum period. The pathogenesis involves a hypercoagulable state induced by pregnancy-related physiological changes, venous stasis from reduced mobility and pelvic compression during delivery, and endothelial injury. Postpartum VTE is a leading cause of maternal morbidity and mortality, necessitating heightened clinical vigilance. Understanding the risk factors, implementing prophylactic measures, and ensuring timely intervention are paramount for improving maternal health outcomes related to venous embolic events. The presented case is a 37-year-old female with a complex medical history marked by recurrent thrombotic events and pregnancy complications. Despite various prophylactic and therapeutic interventions, her condition culminated in severe chronic venous obstruction (CVO) requiring advanced interventional treatment and stent-graft implantation. Her medical history began in 2012 with two spontaneous abortions, leading to the identification of genetic mutations, including a homozygous methylenetetrahydrofolate reductase (MTHFR) mutation. In 2016, she developed PE after receiving hormonal contraceptive therapy without antithrombotic prophylaxis. Subsequent pregnancy was closely monitored, yet she suffered severe complications, including a cesarean delivery complicated by preeclampsia and postoperative thrombocytopenia, leading to massive iliofemoral-popliteal DVT. Initial treatment with vitamin K antagonists (VKA) was replaced with apixaban following a recurrent thrombotic event. Despite optimal anticoagulation, the patient developed symptomatic inferior vena cava (IVC) syndrome in 2022, characterized by chronic IVC occlusion, acute thrombosis of the portal and inferior mesenteric veins, and extensive collateral venous networks. She underwent recanalization and stenting of the iliac veins and IVC. This was followed by a hysterectomy due to metrorrhagia, significantly improving her quality of life. In this case, the homozygous MTHFR mutation was associated with recurrent thrombotic events and pregnancy complications. Despite multiple guidelines advising against MTHFR testing for thrombosis evaluation, the patient's management was influenced by her genetic profile and clinical history. Direct oral anticoagulants (DOACs) have shown efficacy in treating VTE in patients with hereditary thrombophilia. The clinical case also highlights the complexity of anticoagulation management, particularly after venous stenting, where maintaining stent patency poses significant challenges. Venous stenting, especially in CVO, has demonstrated substantial benefits, as evidenced by the patient's marked symptom improvement post-procedure. The long-term efficacy of stenting, optimal anticoagulation strategies, and post-procedural therapy require further research. This case highlights the complexities of managing hereditary thrombophilia with recurrent thrombosis and the evolving role of venous stenting in treating CVO. Individualized anticoagulation and multidisciplinary care are essential, with further studies needed to refine treatment and improve outcomes.

Inherited risk factors for venous thromboembolism

Impact of thrombophilia on venous thromboembolism management

Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis

Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review.

A Comprehensive Review of Risk Factors and Thrombophilia Evaluation in Venous Thromboembolism

[Thrombophilia--diagnostic steps and therapeutic consequences after deep vein thrombosis]

Heterozygous Prothrombin Mutation-Associated Thrombophilia

American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: Thrombophilia Testing

Present Status of Hereditary Thrombophilia

Changes in Biomarkers of Coagulation, Fibrinolytic, and Endothelial Functions for Evaluating the Predisposition to Venous Thromboembolism in Patients with Hereditary Thrombophilia

Navigating Postpartum Venous Thromboembolism: A Case of Thrombophilia, Bleeding Complications, and Chronic Inferior Vena Cava Syndrome

Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment

Impact of Thrombophilia Testing on Clinical Management: A Retrospective Cohort Study

Diagnosis and treatment of venous thromboembolism during pregnancy relate to genetic polymorphism

Thrombophilia Screening: Not So Straightforward

Venous thrombosis

Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta‐analysis

Acquired Risk Factors Play A Major Role In Venous Thrombosis In Chinese Population.

Congenital Thrombophilia in East-Asian Venous Thromboembolism Population: a Systematic Review and Meta-Analysis

Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings

Combined Thrombophilic Risk Factors and Essential Thrombocythemia in Patient with Recurrent Venous Thromboembolic Episodes—Thirty-Three-Year Follow-Up